Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-145739
Filing Date
2025-06-24
Accepted
2025-06-24 16:14:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d76748d424b3.htm 424B3 351762
2 GRAPHIC g76748g01a04.jpg GRAPHIC 66216
  Complete submission text file 0001193125-25-145739.txt   444331
Mailing Address 2617 BISSONNET ST SUITE 233 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 233 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-266841 | Film No.: 251069344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)